Ironwood Pharmaceuticals | IRWD - Ebitda





Ebitda Изменить Дата
Acadia Pharmaceuticals USD 20.31M 15.44M 2025-12
Agios Pharmaceuticals USD -120.31M 4.82M 2025-12
Akebia Therapeutics USD 14.03M 17.19M 2025-03
Almirall EUR 114.07M 60.37M 2025-12
Alnylam Pharmaceuticals USD 145.22M 236.56M 2025-12
Amarin USD 12.54M 28.57M 2025-06
Ardelyx USD 6.02M 447K 2025-12
Astellas Pharma JPY 98.93B 84.75B 2026-03
AstraZeneca USD 5.67B 1.29B 2026-03
Charles River Laboratories USD 229.8M 28.26M 2026-03
Coherus Biosciences USD -43.33M 4.7M 2025-09
Esperion Therapeutics USD -9.93M 24.99M 2025-09
Halozyme Therapeutics USD 219.57M 197.66M 2026-03
Incyte USD 367.97M 46.53M 2026-03
Ironwood Pharmaceuticals USD 81.81M 31.71M 2025-09
Karyopharm Therapeutics USD -26.2M 1.83M 2024-09
Lexicon Pharmaceuticals USD -12.04M 15.95M 2025-09
MacroGenics USD 21.95M 55.39M 2025-09
Moderna USD -790M 582M 2025-12
Myriad Genetics USD 14.3M 4M 2025-12
Pacira USD 40.24M 1.53M 2026-03
PTC Therapeutics USD -70.99M 91.62M 2025-12
Puma Biotechnology USD 729K 11.36M 2024-06
Sarepta Therapeutics USD -252.2M 84.16M 2025-12
Takeda JPY 150.25B 297.88B 2026-03
Ultragenyx Pharmaceutical USD -99.43M 57.35M 2025-12
Vanda Pharmaceuticals USD -8.31M 2.37M 2024-12